Sorry, you need to enable JavaScript to visit this website.

Competitive Grants Program

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Initiatives for Healthcare Professionals to Promote Intramuscular Vaccination Methods for Children
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Efforts to Improve Quality of Migraine Medical Care
    Release Date:
    Partner: The Japanese Headache Society
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Internal Medicine Japan
    Improving Vaccination Systems and Environments to Promote prevention of Respiratory Infections in Older Adults
    Release Date:
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Vaccines Japan
    Optimizing the Experience of Patients with Bladder Cancer Through Multi-Disciplinary Care
    Release Date:
    Partner: Conquer Cancer, the ASCO Foundation
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries
    Release Date:
    Partner: AMFROM
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement Oncology Benin, Congo, The Democratic Republic, Mali, Senegal, Togo
    Clinical Updates and Strategies in the Treatment and Management of First-line BRAF V600E-mutant Metastatic Colorectal Cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology USA
    Guidelines and Best Practices in the Holistic Management of Patients with Metastatic Urothelial Carcinoma (mUC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology USA
    Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management
    Release Date:
    Partner: Beijing Guangda Precision Medicine Research Center
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology China
    COVID-19 Disease Burden on the Pediatric Population
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Post-COVID Conditions: Potential Diagnosis, Testing, Management, and Ongoing Research
    Release Date:
    Review Process: Pfizer Internal
    Education Vaccines USA
    Optimizing Antimicrobial Stewardship Program in Saudi Arabia
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Inflammation & Immunology Saudi Arabia
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Education and Support for Patients with Locally-Advanced or Metastatic Bladder Cancer
    Release Date:
    Partner: Merck KGaA, Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology USA
    Pre-clinical & Translational Research in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Canada, USA
    Management of Patients with BRAF-mutant metastatic colorectal cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease All
    Promotion of Smoking Cessation Treatment in General Practice
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    2021 Growth Hormone Research (All countries except for the United States)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain
    Release Date:
    Partner: Lilly
    Review Process: Pfizer Internal
    Education Internal Medicine All
    NSCLC Therapy Management for Optimal Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom
    Educational Program to Increase Awareness and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease China
    Clinical Research Capability Development
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine China
    Quality Improvement in Pediatric Endocrinology fields
    Release Date:
    Partner: The Japanese Society for Pediatric Endocrinology
    Review Process: Expert Review Panel
    Quality Improvement Rare Disease Japan